IPO registrations (S-1, F-1) · Registrants
MiddleBrook Pharmaceuticals, Inc.
- SEC CIK
- 1161924 · filings on EDGAR ↗
- Name on the registration
- ADVANCIS PHARMACEUTICAL CORP
- Former names
- ADVANCIS PHARMACEUTICAL CORP (2002–2007)
- Registration
- Form S-1, first filed 2003-08-01, last 2003-10-09; 1 initial registration, 3 amendments
- Outcome
- Final prospectus filed 2003-10-17
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Business address
- 20425 SENECA MEADOWS PARKWAY, Germantown, MD 20878
- EIN
- 52-2208264
- EDGAR entity type
- operating
- Insiders and CEO pay
- MiddleBrook Pharmaceuticals, Inc. on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2003-10-09)
- Final price
- $10.00 per share, below the range (424B4 filed 2003-10-17, an initial public offering)
- Shares sold
- 6,000,000
- Gross proceeds
- $60,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol AVNC
- Lead underwriters
- below: Lehman Brothers Inc (2,725,000 shares); Pacific Growth Equities, LLC (1,362,500 shares); Thomas Weisel Partners (1,362,500 shares)
- Syndicate
- Oppenheimer (100,000); Stifel (100,000); Chatsworth Securities LLC (50,000); C.L. King & Associates (50,000); Koonce Securities Inc (50,000); Leerink Partners (50,000); SunTrust Capital Markets, Inc (50,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: MIDDLEBROOK PHARMACEUTICALS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: MIDDLEBROOK PHARMACEUTICALS INC. EXACT (EIN (EXACT))
- Federal award recipient: MIDDLEBROOK PHARMACEUTICALS, INC Fuzzy (name and state)
- SEC filer: ADVANCIS PHARMACEUTICAL CORP EXACT (CIK (EXACT))
- Person page: William W Crouse Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2003-08-01 | S-1 | S-1 (registration) | ADVANCIS PHARMACEUTICAL CORP | 0000950123-03-008868 ↗ |
| 2003-09-05 | S-1/A | S-1/A (amendment) | ADVANCIS PHARMACEUTICAL CORP | 0000950123-03-010144 ↗ |
| 2003-09-29 | S-1/A | S-1/A (amendment) | ADVANCIS PHARMACEUTICAL CORP | 0000950123-03-010920 ↗ |
| 2003-10-09 | S-1/A | S-1/A (amendment) | ADVANCIS PHARMACEUTICAL CORP | 0000950123-03-011208 ↗ |
| 2003-10-17 | 424B4 | 424B4 (final prospectus) | ADVANCIS PHARMACEUTICAL CORP | 0000950123-03-011437 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2003-10-09 | S-1/A | registration statement | $12.00–$14.00 | $13.00 | 6,000,000 | $78,000,000 | Nasdaq AVNC | 1 | primary document; range, price sentence, shares headline, proceeds computed, underwriting table 1 | document ↗ |
| 2003-10-17 | 424B4 | final prospectus | $10.00 | 6,000,000 | $60,000,000 | Nasdaq AVNC | 10 | primary document; price sentence, shares headline, proceeds table, underwriting table 10 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Low Robert C | Officer | Vice President & Acting CFO; Vice President & CFO | 7 | 2006–2008 | |
| RUDNIC EDWARD M | Director,Officer | President and CEO | 15 | 2006–2008 | |
| CAVANAUGH JAMES H | Director,TenPercentOwner | 6 | 2006–2009 | ||
| DUGAN RICHARD W | Director | 4 | 2006–2009 | ||
| HOCKMEYER WAYNE T | Director | 3 | 2006–2008 | ||
| WERNER HAROLD R | Director,TenPercentOwner | 6 | 2006–2009 | ||
| DOUGLAS R GORDON | Director | 4 | 2006–2009 | ||
| AGUIAR ERIC | TenPercentOwner | 1 | 2007 | ||
| CROUSE WILLIAM W | TenPercentOwner | 1 | 2007 | person page Fuzzy | |
| HEALTHCARE PARTNERS VI LP | TenPercentOwner | 1 | 2007 | ||
| HEALTHCARE VENTURES VI LP | TenPercentOwner | 1 | 2007 | ||
| LAWLOR AUGUSTINE | TenPercentOwner | 1 | 2007 | ||
| LITTLECHILD JOHN W | TenPercentOwner | 1 | 2007 | ||
| Mirabelli Christopher | TenPercentOwner | 1 | 2007 | ||
| ATLAS CAPITAL CORP | TenPercentOwner | 1 | 2007 | ||
| KAIROUZ HABIB | TenPercentOwner | 1 | 2007 | ||
| LESCHLY MARK | TenPercentOwner | 1 | 2007 | ||
| Rho Capital Partners LLC | TenPercentOwner | 1 | 2007 | ||
| Rho Investment Partners Q-4 L.P. | TenPercentOwner | 1 | 2007 | ||
| RHO MANAGEMENT PARTNERS L P | TenPercentOwner | 1 | 2007 | ||
| Rho Ventures V Affiliates, LLC | TenPercentOwner | 1 | 2007 | ||
| Rho Ventures V, L.P. | TenPercentOwner | 1 | 2007 | ||
| RMV V, L.L.C. | TenPercentOwner | 1 | 2007 | ||
| RUCH JOSHUA | TenPercentOwner | 1 | 2007 | ||
| VOGELBAUM MARTIN | Director; Director,TenPercentOwner | 4 | 2007–2009 | ||
| Becker David Paul | Officer | EVP & CFO | 2 | 2008 | |
| BURNSIDE BETH A | Officer | SVP, Reg Affairs, Comp & Strat | 2 | 2008 | |
| CHAI TRUST CO LLC | TenPercentOwner | 3 | 2008–2010 | ||
| Cole Brad | Officer | SVP, GC; SVP, General Counsel | 4 | 2008–2010 | |
| EGI-Fund (08-10) Investors, L.L.C. | TenPercentOwner | 3 | 2008–2010 | ||
| EGI-MBRK, L.L.C. | TenPercentOwner | 3 | 2008–2010 | ||
| Miller Timothy L | Officer | SVP, Sales Ops & Admin | 3 | 2008–2009 | |
| PATE WILLIAM | Director | 3 | 2008–2009 | ||
| Sotir Mark R | Director | 3 | 2008–2009 | ||
| SZ INVESTMENTS LLC | TenPercentOwner | 3 | 2008–2010 | ||
| Thievon John | Director,Officer | President and CEO | 2 | 2008 | |
| TREACY DONALD J | Officer | SVP, Devel & Manf Oper | 3 | 2008–2009 | |
| Clausen Susan P | Officer | SVP, Clinical Res & Med Aff | 2 | 2008 | |
| BLYTH LORD JAMES | DirectorOther | 4 | 2008–2009 | ||
| Koos Frank | Officer | SVP, Sales & Business Develop | 2 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | MIDDLEBROOK PHARMACEUTICALS, INC. | TX | State business registries | EIN (EXACT, as the state registration reports it) |
| Federal award recipient | MIDDLEBROOK PHARMACEUTICALS, INC | MD | Federal spending (USAspending) | name and state |
| SEC filer | MiddleBrook Pharmaceuticals, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | MiddleBrook Pharmaceuticals, Inc. | MD | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | MIDDLEBROOK PHARMACEUTICALS INC. | EIN (EXACT) | ||
| Person page | William W Crouse | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MD first:
- NORTHWEST BIOTHERAPEUTICS INC MD
- UNITED THERAPEUTICS Corp MD
- INTERCELL USA, INC. MD
- MACROGENICS INC MD
- AVALON PHARMACEUTICALS INC MD
- IGC Pharma, Inc. MD
- CNBX Pharmaceuticals Inc. MD
- PRECIGEN, INC. MD
- SUPERNUS PHARMACEUTICALS, INC. MD
- Sucampo Pharmaceuticals, Inc. MD
In other datasets, the same topic (Health) in MD:
- Nonprofit: 4K FOR CANCER INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health